Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma
by Christina Black | Dec 7, 2021
Molecular profiling of metastatic renal cell carcinoma treated with ipilimumab-nivolumab
by Christina Black | Nov 19, 2021
Immune and cancer testis antigen landscape in sarcoma
by Christina Black | Nov 19, 2021
Novel immunotherapeutic targets in cancer of unknown primary (CUP)
by Christina Black | Nov 10, 2021
Follow Us on Twitter
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine
Last year, the Buffalo-based cancer diagnostics firm @OmniSeq quietly was acquired by one of the world's largest life science companies, @Labcorp . Developing molecular diagnostic tests for cancer patients, OmniSeq is looking to scale its operations.
https://tinyurl.com/muxryphz